Click for best price
Sustained Release Ocular Drug Delivery Systems Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Sustained Release Ocular Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Ocular Drug Delivery Systems. This report contains market size and forecasts of Sustained Release Ocular Drug Delivery Systems in global, including the following market information:
Global Sustained Release Ocular Drug Delivery Systems Market Revenue, 2018-2023, 20242035, ($ millions)
Global Sustained Release Ocular Drug Delivery Systems Market Sales, 2018-2023, 20242035, (K Pcs)
Global top five Sustained Release Ocular Drug Delivery Systems companies in 2022 (%)
The global Sustained Release Ocular Drug Delivery Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Liposome Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sustained Release Ocular Drug Delivery Systems include pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics and GrayBug, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sustained Release Ocular Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sustained Release Ocular Drug Delivery Systems Market, by Type, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
Global Sustained Release Ocular Drug Delivery Systems Market, by Application, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
Cataract
Glaucoma
Corneal Transplantation
Others
Global Sustained Release Ocular Drug Delivery Systems Market, By Region and Country, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sustained Release Ocular Drug Delivery Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sustained Release Ocular Drug Delivery Systems revenues share in global market, 2022 (%)
Key companies Sustained Release Ocular Drug Delivery Systems sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Sustained Release Ocular Drug Delivery Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sustained Release Ocular Drug Delivery Systems, market overview.
Chapter 2: Global Sustained Release Ocular Drug Delivery Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Sustained Release Ocular Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sustained Release Ocular Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sustained Release Ocular Drug Delivery Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Sustained Release Ocular Drug Delivery Systems Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sustained Release Ocular Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sustained Release Ocular Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sustained Release Ocular Drug Delivery Systems Overall Market Size
2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size: 2022 VS 2035
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Sustained Release Ocular Drug Delivery Systems Sales: 2018-2035
3 Company Landscape
3.1 Top Sustained Release Ocular Drug Delivery Systems Players in Global Market
3.2 Top Global Sustained Release Ocular Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Sustained Release Ocular Drug Delivery Systems Revenue by Companies
3.4 Global Sustained Release Ocular Drug Delivery Systems Sales by Companies
3.5 Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sustained Release Ocular Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Sustained Release Ocular Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sustained Release Ocular Drug Delivery Systems Market Size Markets, 2022 & 2035
4.1.2 Liposome
4.1.3 Microcapsules/Nanocapsules
4.1.4 Microspheres/Nanosptheres
4.1.5 Implants
4.2 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2024-2035
4.2.3 By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
4.3 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
4.3.1 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales, 2018-2023
4.3.2 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales, 2024-2035
4.3.3 By Type - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
4.4 By Type - Global Sustained Release Ocular Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sustained Release Ocular Drug Delivery Systems Market Size, 2022 & 2035
5.1.2 Cataract
5.1.3 Glaucoma
5.1.4 Corneal Transplantation
5.1.5 Others
5.2 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2024-2035
5.2.3 By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
5.3 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
5.3.1 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales, 2018-2023
5.3.2 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales, 2024-2035
5.3.3 By Application - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
5.4 By Application - Global Sustained Release Ocular Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Sustained Release Ocular Drug Delivery Systems Market Size, 2022 & 2035
6.2 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue, 2024-2035
6.2.3 By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
6.3 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
6.3.1 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales, 2018-2023
6.3.2 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales, 2024-2035
6.3.3 By Region - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2035
6.4.2 By Country - North America Sustained Release Ocular Drug Delivery Systems Sales, 2018-2035
6.4.3 US Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.4.4 Canada Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.4.5 Mexico Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2035
6.5.2 By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales, 2018-2035
6.5.3 Germany Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5.4 France Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5.5 U.K. Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5.6 Italy Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5.7 Russia Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5.8 Nordic Countries Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.5.9 Benelux Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2035
6.6.2 By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales, 2018-2035
6.6.3 China Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.6.4 Japan Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.6.5 South Korea Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.6.6 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.6.7 India Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2035
6.7.2 By Country - South America Sustained Release Ocular Drug Delivery Systems Sales, 2018-2035
6.7.3 Brazil Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.7.4 Argentina Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, 2018-2035
6.8.3 Turkey Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.8.4 Israel Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.8.5 Saudi Arabia Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
6.8.6 UAE Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 pSivida
7.1.1 pSivida Company Summary
7.1.2 pSivida Business Overview
7.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.1.5 pSivida Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Icon Bioscience
7.3.1 Icon Bioscience Company Summary
7.3.2 Icon Bioscience Business Overview
7.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.3.5 Icon Bioscience Key News & Latest Developments
7.4 Ocular Therapeutix
7.4.1 Ocular Therapeutix Company Summary
7.4.2 Ocular Therapeutix Business Overview
7.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.4.5 Ocular Therapeutix Key News & Latest Developments
7.5 Neurotech Pharmaceuticals
7.5.1 Neurotech Pharmaceuticals Company Summary
7.5.2 Neurotech Pharmaceuticals Business Overview
7.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.5.5 Neurotech Pharmaceuticals Key News & Latest Developments
7.6 Santen Pharmaceutical
7.6.1 Santen Pharmaceutical Company Summary
7.6.2 Santen Pharmaceutical Business Overview
7.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.6.5 Santen Pharmaceutical Key News & Latest Developments
7.7 Aciont Inc.
7.7.1 Aciont Inc. Company Summary
7.7.2 Aciont Inc. Business Overview
7.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.7.5 Aciont Inc. Key News & Latest Developments
7.8 Envisia Therapeutics
7.8.1 Envisia Therapeutics Company Summary
7.8.2 Envisia Therapeutics Business Overview
7.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.8.5 Envisia Therapeutics Key News & Latest Developments
7.9 GrayBug
7.9.1 GrayBug Company Summary
7.9.2 GrayBug Business Overview
7.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.9.5 GrayBug Key News & Latest Developments
7.10 Innocore Pharmaceuticals
7.10.1 Innocore Pharmaceuticals Company Summary
7.10.2 Innocore Pharmaceuticals Business Overview
7.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.10.5 Innocore Pharmaceuticals Key News & Latest Developments
7.11 OHR Pharmaceuticals
7.11.1 OHR Pharmaceuticals Company Summary
7.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Business Overview
7.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.11.5 OHR Pharmaceuticals Key News & Latest Developments
7.12 PolyActiva
7.12.1 PolyActiva Company Summary
7.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Business Overview
7.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.12.5 PolyActiva Key News & Latest Developments
7.13 TheraKine
7.13.1 TheraKine Company Summary
7.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Business Overview
7.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.13.5 TheraKine Key News & Latest Developments
8 Global Sustained Release Ocular Drug Delivery Systems Production Capacity, Analysis
8.1 Global Sustained Release Ocular Drug Delivery Systems Production Capacity, 2018-2035
8.2 Sustained Release Ocular Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Sustained Release Ocular Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sustained Release Ocular Drug Delivery Systems Supply Chain Analysis
10.1 Sustained Release Ocular Drug Delivery Systems Industry Value Chain
10.2 Sustained Release Ocular Drug Delivery Systems Upstream Market
10.3 Sustained Release Ocular Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sustained Release Ocular Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Sustained Release Ocular Drug Delivery Systems in Global Market
Table 2. Top Sustained Release Ocular Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Sustained Release Ocular Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Sustained Release Ocular Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2018-2023
Table 15. By Type - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2024-2035
Table 16. By Application ? Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2018-2023
Table 20. By Application - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2024-2035
Table 21. By Region ? Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2018-2023
Table 25. By Region - Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), 2024-2035
Table 26. By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2024-2035
Table 30. By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2024-2035
Table 34. By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2024-2035
Table 38. By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2024-2035
Table 42. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, (K Pcs), 2024-2035
Table 46. pSivida Company Summary
Table 47. pSivida Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 48. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. pSivida Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 52. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. Icon Bioscience Company Summary
Table 55. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 56. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Icon Bioscience Key News & Latest Developments
Table 58. Ocular Therapeutix Company Summary
Table 59. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 60. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Ocular Therapeutix Key News & Latest Developments
Table 62. Neurotech Pharmaceuticals Company Summary
Table 63. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 64. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Neurotech Pharmaceuticals Key News & Latest Developments
Table 66. Santen Pharmaceutical Company Summary
Table 67. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 68. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Santen Pharmaceutical Key News & Latest Developments
Table 70. Aciont Inc. Company Summary
Table 71. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 72. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Aciont Inc. Key News & Latest Developments
Table 74. Envisia Therapeutics Company Summary
Table 75. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 76. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Envisia Therapeutics Key News & Latest Developments
Table 78. GrayBug Company Summary
Table 79. GrayBug Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 80. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. GrayBug Key News & Latest Developments
Table 82. Innocore Pharmaceuticals Company Summary
Table 83. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 84. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Innocore Pharmaceuticals Key News & Latest Developments
Table 86. OHR Pharmaceuticals Company Summary
Table 87. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 88. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. OHR Pharmaceuticals Key News & Latest Developments
Table 90. PolyActiva Company Summary
Table 91. PolyActiva Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 92. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. PolyActiva Key News & Latest Developments
Table 94. TheraKine Company Summary
Table 95. TheraKine Sustained Release Ocular Drug Delivery Systems Product Offerings
Table 96. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. TheraKine Key News & Latest Developments
Table 98. Sustained Release Ocular Drug Delivery Systems Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 99. Global Sustained Release Ocular Drug Delivery Systems Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Sustained Release Ocular Drug Delivery Systems Production by Region, 2018-2023 (K Pcs)
Table 101. Global Sustained Release Ocular Drug Delivery Systems Production by Region, 2024-2035 (K Pcs)
Table 102. Sustained Release Ocular Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 103. Sustained Release Ocular Drug Delivery Systems Market Drivers in Global Market
Table 104. Sustained Release Ocular Drug Delivery Systems Market Restraints in Global Market
Table 105. Sustained Release Ocular Drug Delivery Systems Raw Materials
Table 106. Sustained Release Ocular Drug Delivery Systems Raw Materials Suppliers in Global Market
Table 107. Typical Sustained Release Ocular Drug Delivery Systems Downstream
Table 108. Sustained Release Ocular Drug Delivery Systems Downstream Clients in Global Market
Table 109. Sustained Release Ocular Drug Delivery Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Segment by Type in 2022
Figure 2. Sustained Release Ocular Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sustained Release Ocular Drug Delivery Systems Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2035 (US$, Mn)
Figure 7. Sustained Release Ocular Drug Delivery Systems Sales in Global Market: 2018-2035 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Sustained Release Ocular Drug Delivery Systems Revenue in 2022
Figure 9. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 11. By Type - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 12. By Type - Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs), 2018-2035
Figure 13. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 15. By Application - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 16. By Application - Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs), 2018-2035
Figure 17. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 20. By Region - Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 21. By Country - North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 22. By Country - North America Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 23. US Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 28. Germany Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 29. France Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 37. China Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 41. India Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 43. By Country - South America Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 44. Brazil Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2035
Figure 48. Turkey Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Sustained Release Ocular Drug Delivery Systems Revenue, (US$, Mn), 2018-2035
Figure 52. Global Sustained Release Ocular Drug Delivery Systems Production Capacity (K Pcs), 2018-2035
Figure 53. The Percentage of Production Sustained Release Ocular Drug Delivery Systems by Region, 2022 VS 2035
Figure 54. Sustained Release Ocular Drug Delivery Systems Industry Value Chain
Figure 55. Marketing Channels
